دورية أكاديمية

Niraparib and dostarlimab for the treatment of recurrent platinum-resistant ovarian cancer: results of a Phase II study (MOONSTONE/GOG-3032)

التفاصيل البيبلوغرافية
العنوان: Niraparib and dostarlimab for the treatment of recurrent platinum-resistant ovarian cancer: results of a Phase II study (MOONSTONE/GOG-3032)
المؤلفون: Randall, Leslie M., O'Malley, David M., Monk, Bradley J., Coleman, Robert L., Gaillard, Stephanie, Adams, Sarah, Duska, Linda R., Dalton, Heather, Holloway, Robert W., Huang, Marilyn, Chon, Hye Sook, Cloven, Noelle G., ElNaggar, Adam C., O'Cearbhaill, Roisin E., Waggoner, Steven, Tarkar, Aarti, Striha, Alina, Nelsen, Linda M., Baines, Amanda, Samnotra, Vivek, Konstantinopoulos, Panagiotis A.
المصدر: Gynecologic Oncology ; volume 178, page 161-169 ; ISSN 0090-8258
بيانات النشر: Elsevier BV
سنة النشر: 2023
المجموعة: ScienceDirect (Elsevier - Open Access Articles via Crossref)
مصطلحات موضوعية: Obstetrics and Gynecology, Oncology
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1016/j.ygyno.2023.10.005
الإتاحة: https://doi.org/10.1016/j.ygyno.2023.10.005Test
https://api.elsevier.com/content/article/PII:S0090825823014981?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S0090825823014981?httpAccept=text/plainTest
حقوق: https://www.elsevier.com/tdm/userlicense/1.0Test/ ; https://doi.org/10.15223/policy-017Test ; https://doi.org/10.15223/policy-037Test ; https://doi.org/10.15223/policy-012Test ; https://doi.org/10.15223/policy-029Test ; https://doi.org/10.15223/policy-004Test
رقم الانضمام: edsbas.4DC1FACE
قاعدة البيانات: BASE